TD Asset Management
CVAC

TD Asset Management’s CureVac CVAC Stock Holding History

TD Asset Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-209,094
Closed -$1.43M – 1405
2023
Q3 		$1.43M Buy
209,094
+83,747
+67% +$740K ﹤0.01% 1049
2023
Q2 		$1.31M Sell
125,347
-27,249
-18% -$244K ﹤0.01% 1068
2023
Q1 		$1.06M Buy
152,596
+112,096
+277% +$977K ﹤0.01% 1121
2022
Q4 		$244K Buy
+40,500
New +$299K ﹤0.01% 1375
2022
Q2 		– Sell
-34,900
Closed -$684K – 1472
2022
Q1 		$684K Hold
34,900
– – ﹤0.01% 1301
2021
Q4 		$1.2M Hold
34,900
– – ﹤0.01% 1244
2021
Q3 		$1.91M Buy
+34,900
New +$2.1M ﹤0.01% 1100
2021
Q2 		– Sell
-35,125
Closed -$3.21M – 1530
2021
Q1 		$3.21M Buy
35,125
+5,995
+21% +$582K ﹤0.01% 952
2020
Q4 		$2.36M Buy
+29,130
New +$2.23M ﹤0.01% 992

Other funds holding CVAC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TD Asset Management's CVAC Position: Q4 2023 in Review

TD Asset Management sold out of CureVac (CVAC) in Q4 2023, closing a stake of 209,094 shares — an estimated $1.43M sold.

TD Asset Management first reported a position in CVAC in Q4 2020 and held it in 9 quarters. The position peaked at $3.21M in Q1 2021. 90 funds tracked by Wall St. Rank hold CVAC as of Q4 2023.

  • TD Asset Management reported no remaining CureVac position as of Q4 2023 after selling out during the quarter.
  • TD Asset Management sold 209,094 CureVac shares in Q4 2023, an estimated $1.43M.
  • TD Asset Management first reported a position in CureVac in Q4 2020 and held it in 9 quarters.
  • TD Asset Management's CureVac position peaked at $3.21M in Q1 2021.
  • 90 funds tracked by Wall St. Rank held CureVac as of Q4 2023.

Based on TD Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.